DDInter645 DDInter808
Enoxaparin is a common low-molecular-weight heparin (LMWH) used in the prevention and management of various thromboembolic disorders. Initially approved by the FDA in 1993, it is administered by a subcutaneous or intravenous injection and marketed by several pharmaceutical companies. Enoxaparin markedly reduces the incidence of venous thromboembolism in hospitalized patients when compared to unfractionated [heparin], without increasing the risk of serious bleeding.[A228178,A228313]
Garlic allergenic extract is used in allergenic testing.
Enoxaparin {u} (Compound) binds {v} (Gene) SERPINC1
Enoxaparin {u} (Compound) is included by {v} (Pharmacologic Class) Heparin, Low-Molecular-Weight
Enoxaparin {u} (Compound) causes {v} (Side Effect) Epidural haemorrhage
Enoxaparin {u} may cause a minor interaction that can limit clinical effects when taken with {v} Turmeric
Enoxaparin {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Phenyl salicylate
Enoxaparin {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Valdecoxib
Enoxaparin {u} may lead to a major life threatening interaction when taken with {v} Dipyridamole
Enoxaparin {u} may lead to a major life threatening interaction when taken with {v} Vorapaxar
Enoxaparin (Compound) binds SERPINC1 (Gene)
Enoxaparin (Compound) is included by Heparin, Low-Molecular-Weight (Pharmacologic Class)
Enoxaparin (Compound) causes Epidural haemorrhage (Side Effect)
Enoxaparin may cause a minor interaction that can limit clinical effects when taken with Turmeric
Enoxaparin may cause a moderate interaction that could exacerbate diseases when taken with Phenyl salicylate
Enoxaparin may cause a moderate interaction that could exacerbate diseases when taken with Valdecoxib
Enoxaparin may lead to a major life threatening interaction when taken with Dipyridamole
Enoxaparin may lead to a major life threatening interaction when taken with Vorapaxar